SEPARATION AGREEMENTSeparation Agreement • March 8th, 2006 • Neose Technologies Inc • Medicinal chemicals & botanical products • Pennsylvania
THIS SEPARATION AGREEMENT (this “Agreement”), dated as of October 31, 2005 by and between NEOSE TECHNOLOGIES, INC. (the “Company”) and MARJORIE A. HURLEY, PHARM.D (“Dr. Hurley”).
Amendment Number 3 to the Research, Development and License AgreementNeose Technologies Inc • March 8th, 2006 • Medicinal chemicals & botanical products
This Amendment Number 3 to the Agreement (as defined below)(the “Amendment”) is effective as of December 15, 2005 (the “Effective Date”), and is by and among Novo Nordisk A/S, a corporation organized and existing under the laws of Denmark, Novo Nordisk Health Care AG, a corporation organized and existing under the laws of Switzerland (collectively, Novo Nordisk A/S and Novo Nordisk Health Care AG are hereinafter referred to as “Novo”), and Neose Technologies, Inc., a corporation organized and existing under the laws of the state of Delaware (hereinafter referred to as “Neose”).
SEPARATION AGREEMENTSeparation Agreement • March 8th, 2006 • Neose Technologies Inc • Medicinal chemicals & botanical products • Pennsylvania
THIS SEPARATION AGREEMENT (this “Agreement”), dated as of October 31, 2005 by and between NEOSE TECHNOLOGIES, INC. (the “Company”) and JOSEPH J. VILLAFRANCA, PH.D. (“Dr. Villafranca”).
